Overview
Akifumi Kushiyama practices in Tokyo, Japan. Kushiyama is rated as an Experienced expert by MediFind in the treatment of Autonomic Neuropathy. Their top areas of expertise are Nonalcoholic Steatohepatitis (NASH), Diabetic Retinopathy, Type 2 Diabetes (T2D), and Metabolic Syndrome.
Their clinical research consists of co-authoring 92 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Autonomic Neuropathy.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Diabetic RetinopathyKushiyama isAdvanced. Learn about Diabetic Retinopathy.
- Metabolic SyndromeKushiyama isAdvanced. Learn about Metabolic Syndrome.
- Non-Alcoholic Fatty Liver Disease
- Nonalcoholic Steatohepatitis (NASH)
- Type 2 Diabetes (T2D)Kushiyama isAdvanced. Learn about Type 2 Diabetes (T2D).
- Experienced
- Abdominal Obesity Metabolic SyndromeKushiyama isExperienced. Learn about Abdominal Obesity Metabolic Syndrome.
- AtherosclerosisKushiyama isExperienced. Learn about Atherosclerosis.
- Autonomic NeuropathyKushiyama isExperienced. Learn about Autonomic Neuropathy.
- Chronic Kidney DiseaseKushiyama isExperienced. Learn about Chronic Kidney Disease.
- CirrhosisKushiyama isExperienced. Learn about Cirrhosis.
- Diabetic Macular Edema (DME)Kushiyama isExperienced. Learn about Diabetic Macular Edema (DME).